Monthly eye injections of Avastin (bevacizumab) are as effective as the more expensive drug Eylea (aflibercept) for the treatment of central retinal vein occlusion (CRVO), according to a clinical trial. After six monthly injections, treatment with either drug improved visual acuity on average from 20/100 to 20/40.